Reviewer
Alexander V Ivanov
  • Faculty, Engelhardt institute of molecular biology, Russian academy of sciences
Research focus
  • Biochemistry
  • hepatitis C virus; hepatitis B virus; hepatitis delta virus; polyamines; spermine; spermidine; reactive oxygen species; Nrf2; metabolism; polymerase; replication

Education

PhD, Engelhardt institute of molecular biology, 2006

Lab information

Laboratory of biochemistry of viral infections (Alex Ivanov lab)

Publications

LIST OF PUBLICATIONS
1. Fedorova N.E., Chernoryzh Y.Y., Vinogradskaya G.R., Emelianova S.S., Zavalyshina L.E., Yurlov K.I., Zakirova N.F., Verbenko V.N., Kochetkov S.N., Kushch A.A., Ivanov AV. Inhibitor of polyamine catabolism MDL72.527 restores the sensitivity to doxorubicin of monocytic leukemia Thp-1 cells infected with human cytomegalovirus. Biochimie., 2019, 158, 82-89.
2. Ivanova O.N., Snezhkina A.V., Krasnov G.S., Valuev-Elliston V.T., Khomich O.A., Khomutov A.R., Keinanen T.A., Alhonen L., Bartosch B., Kudryavtseva A.V., Kochetkov S.N., Ivanov A.V. Activation of polyamine catabolism by N1,N11-diethylnorspermine in hepatic HepaRG cells induces dedifferentiation and mesenchymal-like phenotype. Cells, 2018, 7, 275.
3. Masalova O., Lesnova E., Onishchuk A., Ivanova A., Gerasimova E., Ivanov A., Narovlyansky A., Sanin A., Pronin A., Kushch A. Polyprenyl phosphates induce a high humoral and cellular response to immunization with recombinant proteins of the replicative complex of the hepatitis C virus. 2018; Doklady Biochemistry and Biophysics. 2018; 482(1), 261–263.
4. Emelyanova S., Chernoryzh Ya., Yurlov K., Fedorova N., Ivanov A., Kochetkov S., Verbenko V., Kushch A., Vinogradskaya G. Participation of transcriptional factors E2F1 and P73 in the development of doxorubicin resistance in the tumorous cells THP-1 infected with human cytomegalovirus. 2018; Tsitologiya. 2018; 60(7), 527-530.
5. Masalova O.V., Lesnova E.I., Solyev P.N., Zakirova N.F., Prassolov V.S., Kochetkov S.N., Ivanov A.V.*, Kushch A.A. Modulation of cell death pathways by hepatitis C virus proteins in Huh7.5 hepatoma cells. Int. J. Mol. Sci., 2017, 18, №11, E2346.
6. Latanova A, Petkov S., Kuzmenko Yu., Kilpeläinen A., Ivanov A., Smirnova O., Krotova O., Korolev S., Hinkula J., Karpov V., Isaguliants M., Starodubova E. Fusion to flaviviral leader peptide targets HIV-1 reverse transcriptase for secretion, reduces its enzymatic activity and ability to induce oxidative stress, but has no major effects on its immunogenic performance in DNA-immunized mice. J. Immunol. Res. 2017, vol. 2017, Article ID 7407136.
7. Smirnova O.A., Keinanen T.A., Ivanova O.N., Hyvonen M.T., Khomutov A.R., Kochetkov S.N., Bartosch B., Ivanov A.V. Hepatitis C virus alters metabolism of biogenic polyamines by affecting expression of key enzymes of their metabolism. Biochem. Biophys. Res. Commun., 2017, 483, 904-909.
8. Kuzmenko Yu.V., Smirnova O.A., Ivanov A.V., Starodubova E.S., Karpov V.L. The nonstructural protein 1 of tick-borne encephalitis virus induces oxidative stress and activates antioxidant defense by Nrf2/ARE pathway. Intervirology, 2016, 59(2), 111–117.
9. Tunitskaya V.L., Eliseeva O.V., Valuev-Elliston V.T., Tyurina D.A., Zakirova N.F., Khomich O.A., Kalis M., Latyshev O.E., Starodubova E.S., Ivanova O.N., Kochetkov S.N., Isaguliants M.G., Ivanov A.V. Prokaryotic Expression, purification and immunogenicity in rabbits of small antigen of hepatitis delta virus. Int. J. Mol. Sci., 2016, 17(10), 1721.
10. Smirnova O.A., Ivanova O.N., Mukhtarov F.Ch., Tunitskaya V.L., Jansons J., Isaguliants M.G., Kochetkov S.N., Ivanov A.V. Analysis of the domains of hepatitis C virus core and NS5A proteins that activate Nrf2/ARE cascade. Acta Naturae, 2016, 8(3), 155-159.
11. Magri A., Ozerov A.A., Tunitskaya V.L., Valuev-Elliston V.T., Wahid A., Pirisi M., Simmonds P., Ivanov A.V., Novikov M.S., Patel A.H. Exploration of acetanilide derivatives of 1-(ω-phenoxyalkyl)uracils as novel inhibitors of Hepatitis C Virus replication, Scientific Reports, 2016, vol. 6, article number 29487.
12. Chudinov M.V., Matveev A.V., Prutkov A.N., Konskantinova I.D., Fateev I.V., Prasolov V.S., Smirnova O.A., Ivanov A.V., Galegov G.A., Deryabin P.G. Novel 5-alkyl(aryl)-substituted ribavirine analogues: synthesis and antiviral activity. Mendeleev Commun., 2016, 26(3), 214-216.
13. Masalova O.V., Lesnova E.I, Permiakova K.Yu, Samokhvalov E.I., Ivanov A.V., Kochetkov S.N., Kushch A.A. The impact of hepatitis C virus proteins on production of proinflammatory and profibrotic cytokines in human hepatoma Huh7.5 cells. Molecular Biology (Moscow), 2016, 50(3), (in Russian 486-495).
14. Beljelarskaya S.N., Orlova O.V., Drutsa V.L., Orlov V.A., Timohova A.V., Korolev N.N., Popenko V.I., Ivanov A.V., Spirin P.V., Prassolov V.S., Rubtsov P.M., Kochetkov S.N., Hepatitis C virus: The role of N-glycosylation sites of viral genotype 1b proteins for formation of viral particles in insect and mammalian cells. Biochemistry and Biophysics Reports, 2016, 7, 98–105
15. Koloskova O.O., Nikonova A.A., Budanova U.A., Shilovskiy I.P., Kofiadi I.A., Ivanov A.V., Smirnova O.A., Zverev V.V., Sebaykin Yu.L., Andreev S.M., Khaitov M.R. Synthesis and evaluation of novel lipopeptide as a vehicle for efficient gene delivery and gene silencing. Eur. J. Pharm. Biopharm., 2016, 102, 159-167.
16. Smirnova O.A., Ivanova O.N., Bartosch B., Valuev-Elliston V.T., Mukhtarov F., Kochetkov S.N., Ivanov A.V. Hepatitis C virus NS5A protein triggers oxidative stress by inducing NADPH oxidases 1 and 4 and cytochrome P450 2E1. Oxid. Med. Cell. Longev., 2016, vol. 2016, Article ID 8341937. doi:10.1155/2016/8341937.
17. Brault C., Lévy C., Duponchel S., Michelet M., Sallé A., Pécheur E.-I., Plissonnier M.-L., Parent R., Véricel E., Ivanov A.V., Demir M., Steffen H.-M., Odenthal M, Zoulim F., Bartosch B. Glutathione peroxidase 4 is reversibly induced by HCV to control lipid peroxidation and to increase virion infectivity. Gut, 2016, 65(1), 144-154.
18. Ivanov A.V., Smirnova O.A., Petrushanko I.Yu., Ivanova O.N., Karpenko I.L., Alekseeva E., Sominska I., Makarov A.A., Bartosch B., Kochetkov S.N., Isaguliants M.G. HCV core protein uses multiple mechanisms to induce oxidative stress in human hepatoma Huh7 cells. Viruses, 2015, 7(6), 2745-2770.
19. Babkov D.A., Valuev-Elliston V.T., Paramonova M.P., Ozerov A.A., Ivanov A.V., Chizhov A.O., Khandazhinskaya A.L., Kochetkov S.N., Balzarini J., Daelemans B., Pannecouque C., Seley-Radtke K.L., Novikov M.S. Scaffold hopping: Exploration of acetanilide-containing uracil analogues as potential NNRTIs. Bioorg. Med. Chem. 2015; 23, 1069-1081.
20. Orlova O.V., Drutsa V.L., Spirin P.V., Ivanov A.V., Prasolov V.S., Rubtsov P.M., Kochetkov S.N., Beljelarskaya S.N. The role of HCV e2 protein glycosylation in functioning of virus envelope proteins in insect and mammalian cells. Acta Naturae, 2015, 7(1), 87-97.
21. Masalova O.V., Lesnova E.I., Permyakova K.Yu., Ivanova A.V., Tunitskaya V.L., Kushch А.А. Enhancement of the Immune Response by Codelivery of Hepatitis C Virus Recombinant DNA and Proteins of the Replicative Complex. Molecular Genetics, Microbiology and Virology, 2015, 30(1), 39-47.
22. Isaguliants M., Smirnova O., Ivanov A., Kilpelainen A., Kuzmenko Yu., Petkov S., Latanova A., Krotova O., Engström G., Karpov V., Kochetkov S., Wahren B., Starodubova E. Oxidative stress induced by HIV-1 reverse transcriptase modulates its performance in gene immunization. 2013; Hum Vaccin Immunother. 2013; 9(10), 2111 - 2119.
23. Matyugina E.S., Valuev-Elliston V.T., Babkov D.A., Novikov M.S., Ivanov A.V., Kochetkov S.N., Balzarini J., Seley-Radtke K.L., Khandazhinskaya A.L. 5’-Nor carbocyclic nucleosides: unusual nonnucleoside inhibitors of HIV-1 reverse transcriptase. Med. Chem. Comm. 2013; 4, 741-748.
24. Novikov M.S., Valuev-Elliston V.T., Babkov D.A., Paramonova M.P., Ivanov A.V., Gavryushov S.A., Khandazhinskaya A.L., Kochetkov S.N., Pannecouque C., Andrei G., Snoeck R., Balzarini J., Seley-Radtke K.L. N1-substituted 3-benzylpyrimidines as nonnucleoside inhibitors of HIV-1 reverse transcriptase. Bioorg. Med. Chem. 2013; 21(5):1150-1158.
25. Prokofjeva M.M., Valuev-Elliston V.T., Ivanov A.V., Kochetkov S.N., Novikov M.S., Prassolov V.S. Derivatives of Pyrimidines as Effective Non-nucleoside Inhibitors of Wild-Type and Drug-Resistant HIV-1 Reverse Transcriptase. Doklady Biochemistry and Biophysics, 2012, 447, 280–281.
26. Timokhova A.V., Bakinovskii L.V., Zinin A.I., Popenko V.I., Ivanov A.V., Rubtsov P.M., Kochetkov S.N., Belzhelarskaya S.N. Effect of deoxynojirimycin derivatives on morphogenesis of hepatitis C virus. Molecular Biology (Moscow). 2012; 46(4), 579-587.
27. Valuev-Elliston V.T., Ivanov A.V., Orlinson B.S., Gerasimov E.N., Brunilina L.L., Kochetkov S.N., Novakov I.A., Navrotskii M.B. Synthesis and biological activity of new 6-benzylisocytosine derivatives: non-nucleoside HIV-1 reverse transcriptase inhibitors. Pharmaceutical Chemistry Journal, 2012, 46(7), 397-401.
28. Korovina A.N., Tunitskaya V.L., Khomutov M.A., Simonian A.R., Khomutov A.R., Ivanov A.V.*, Kochetkov S.N. Biogenic polyamines spermine and spermidine stabilize RNA polyamerase and inhibit RNA helicase of hepatitis C virus. Biochemistry (Moscow), 2012, 77(10), 1172-1180.
29. Smirnova O.A., Isaguliants M.G., Hyvonen M.T., Keinanen T.A., Tunitskaya V.L., Vepsalainen J., Alhonen L., Kochetkov S.N., Ivanov A.V. Chemically induced oxidative stress increases polyamine levels by activating the transcription of ornithine decarboxylase and spermidine/spermine-N1-acetyltransferase in human hepatoma HUH7 cells. Biochimie, 2012, 94(9), 1876-1883.
30. Ivanov A.V., Smirnova O.A., Ivanova O.N., Masalova O.V., Kochetkov S.N., Isaguliants M.G. Hepatitis C Virus Proteins Activate NRF2/ARE Pathway by Distinct ROS-Dependent and Independent Mechanisms in HUH7 cells. PLoS One, 2011, 6(9), e24957.
31. Novikov M.S., Ivanova O.N., Ivanov A.V., Ozerov A.A., Valuev-Elliston V.T., Temburnikar K., Gurskaya G.V., Kochetkov S.N., Pannecouque C., Balzarini J., Seley-Radtke K.L. 1-[2-(2-Benzoyl- and 2-benzylphenoxy)ethyl]uracils as potent anti-HIV-1 agents. Bioorg. Med. Chem. 2011; 19(19), 5794-5802.
32. Tunitskaya V.L., Mukovnya A.V., Ivanov A.A., Gromyko A.V., Ivanov A.V., Streltsov S.A., Zhuze A.L., Kochetkov S.N. Inhibition of the helicase activity of the HCV NS3 protein by symmetrical dimeric bis-benzimidazoles. Bioorg. Med. Chem. Letters 2011, 21(18), 5331-5335.
33. Prokofjeva M.M., Spirin P.V., Yanvarev D.V., Ivanov A.V., Novikov M.S., Stepanov O.A., Gottikh M.B., Kochetkov S.N., Fehse B., Stocking C., Prassolov V.S. Screening of Potential HIV-1 Inhibitors/Replication Blockers Using Secure Lentiviral in Vitro System. Acta Naturae. 2011. 3(4), 55-65.
34. Novikov MS, Buckheit RW Jr, Temburnikar K, Khandazhinskaya AL, Ivanov AV, Seley-Radtke KL. 1-Benzyl derivatives of 5-(arylamino)uracils as anti-HIV-1 and anti-EBV agents. Bioorg. Med. Chem. 2010; 18(23), 8310-4.
35. Masalova O.V., Lesnova E.I., Grabovetsky I.I., Smirnova O.A., Ulanova T.I., Burkov A.U., Ivanov A.V., Zaberezhniy A.V., Ataulkhanov A.I., Kusch A.A. DNA immunization by a plasmid encoding a hepatitis C virus nonstructural NS5A protein induces an effective cellular immune response. Molecular Biology (Moscow). 2010; 44(2), 275-83.
36. Karpenko I, Deev S, Kiselev O, Charushin V, Rusinov V, Ulomsky E, Deeva E, Yanvarev D, Ivanov A, Smirnova O, Kochetkov S, Chupakhin O, Kukhanova M. Antiviral properties, metabolism, and pharmacokinetics of a novel azolo-1,2,4-triazine-derived inhibitor of influenza A and B virus replication. Antimicrob Agents Chemother. 2010; 54(5), 2017-22.
37. Masalova OV, Lesnova EI, Pichugin AV, Melnikova TM, Grabovetsky VV, Petrakova NV, Smirnova OA, Ivanov AV, Zaberezhny AD, Ataullakhanov RI, Isaguliants MG, Kushch AA. The successful immune response against hepatitis C nonstructural protein 5A (NS5A) requires heterologous DNA/protein immunization. Vaccine. 2010; 28(8), 1987-96.
38. Starodubova E, Boberg A, Ivanov A, Latyshev O, Petrakova N, Kuzmenko Y, Litvina M, Chernousov A, Kochetkov S, Karpov V, Wahren B, Isaguliants MG. Potent cross-reactive immune response against the wild-type and drug-resistant forms of HIV reverse transcriptase after the chimeric gene immunization. Vaccine. 2010, 28(8), 1975-86.
39. Matyugina E.S., Alexandrova L.A., Jas'ko M.V., Ivanov A.V., Vasil'ev I.A., Lapteva V.L., Khandazhinskaya A.L., Kukhanova M.K. Structure-functional analysis of interactions of terminal deoxynucleotidyl transferase with new non-nucleoside substrates. Russ. J. Bioorg. Chem., 2009, 35, 376-383.
40. Ivanov A.V., Tunitskaya V.L., Ivanova O.N., Mitkevich V.A., Prassolov V.S., Makarov A.A., Kukhanova M.K., Kochetkov S.N. Hepatitis C virus NS5A protein modulates template selection by the RNA polymerase in in vitro system. FEBS Letts., 2009, 583, №2, 277-280.
41. Ivanov M.A., Ivanov A.V., Krasnitskaya I.A., Smirnova O.A., Karpenko I.L., Belanov E.F., Prassolov V.S., Tunitskaya V.L., Alexandrova L.A. New furano- and pyrrolo[2,3-d]pyrimidine nucleosides and their 5’-triphosphates: synthesis and biological properties. Russ. J. Bioorg. Chem., 2008, 34, №5, 661-670.
42. Seley-Radtke K.L., Zhang Z., Wauchope O.R., Zimmermann S.C., Ivanov A., Korba B. Hetero-expanded nucleosides. Design, synthesis and preliminary biological activity. Nucleic Acids Symp. Ser. (Oxf.), 2008, №52, 635-636.
43. Ivanov A.V., Smirnova O.A., Golubeva N.A., Ivanov M.A., Tunitskaya V.L., Shipitsyn A.V., Alexandrova L.A. Base-modified ribonucleosides as potential anti-hepatitis C virus agents. Nucleic Acids Symp. Ser. (Oxf.), 2008, №52, 619-620.
44. Mukovnya A.V., Tunitskaya V.L., Khandazhinskaya A.L., Golubeva N.A., Zakirova N.F., Ivanov A.V., Kukhanova M.K., Kochetkov S.N. Hepatitis C virus helicase/NTPase: an efficient expression system and new inhibitors. Biochemistry (Mosc), 2008, 73, №6, 660-668.
45. Golubeva N.A., Ivanov A.V., Ivanov M.A., Batyunina O.A., Shipitsyn A.V., Tunitskaya V.L., Aleksandrova L.A. New Nucleoside Analogues and Their 5'-Triphosphates: Synthesis and Biological Properties. Moscow University Chemistry Bulletin, 2008, 63, №2, 89–93.
46. Korovina A.N., Yasco M.V., Ivanov A.V., Khandazhinskaya A.L., Karamov E.V., Kornilayeva G.V., Kukhanova M.K. New HSV and HIV replication inhibitors on the abse of phosphonate nucleoside analogues. Moscow University Chemistry Bulletin, 2008, 63, №2, 108-111.
47. Jasko M, Khandazhinskaya A, Alexandrova L, Shirokova E, Ivanov A, Kukhanova M. Synthesis of novel alkyl triphosphates and their substrate properties toward terminal deoxynucleotidyltransferase. Nucleosides Nucleotides Nucleic Acids, 2007, 26, № 4, 323-34.
48. Kozlov M.V., Polyakov K.M., Ivanov A.V., Filippova S.E., Kuzyakin A.O., Tunitskaya V.L., Kochetkov S.N. Hepatitis C virus RNA-dependent RNA polymerase: study of inhibition mechanism by pyrogallole derivatives Biochemistry (Moscow), 2006, 71, 1253-1259.
49. Ivanov A.V., Korovina A.N., Tunitskaya V.L., Kostyuk D.A., Rechinsky V.O., Kukhanova M.K., Kochetkov S.N. Development of the system ensuring a high-level expression of hepatitis C virus nonstructural NS5B and NS5A proteins. Prot. Exp. Purif., 2006, 48, №1, 14-23.
50. Kukhanova M.K., Zakirova N.F., Ivanov A.V., Alexandrova L.A., Jasco M.V., Khomutov A.R. Hypophosphoric acid is a unique substrate of pyrophosphorolysis catalyzed by HIV-1 reverse transcriptase. Biochem. Biophys. Res. Commun., 2005, 338, 1335-1341.
51. Kukhanova M.K., Ivanov A.V., Jasko M.V. Structure-functional relationship between terminal deoxynucleotidytransferase and 5’-triphosphates of nucleoside analogues, Biochemistry (Moscow), 2005, 70, 890-896.
52. Ivanov A.V., Simonyan A.R., Belanov E.F., Alexandrova L.A. Novel 5-modified derivatives of 2'-deoxynucleosides: synthesis and antiviral activity, Russ. J. Bioorg. Chem., 2005, 31, 65-72.
53. Ivanov A.V., Andronova V.L., Galegov G.A., Jasko M.V. Synthesis and antiherpetic activity of (Z)- and (E)- isomers of 9-(3-phosphonylmethoxypropen-1-yl)adenine, Russ. J. Bioorg. Chem., 2005, 31, №1, 58-65.
54. Ivanov A.V., Kozlov M.V, Kuzyakin A.O., Kostyuk D.A., Tunitskaya V.L., Kochetkov S.N. New non-nucleoside inhibitors of hepatitis C virus RNA-dependent RNA polymerase Biochemistry (Moscow), 2004, 69, № 7, 782-788.
55. Kochetkov S.N., Andreeva O.I, Ivanov A.V., Kozlov M.V, Mikhailov S.N. Tunitskaya V.L. New blockators of human immunodeficiency and hepatitis C viruses Molecular Medicine (Moscow), 2004, 3, 41-48
56. Shirokova E.A., Jasko M.V., Khandazhinskaya A.L., Ivanov A.V., Yanvarev D.V., Skoblov Y.S., Mitkevich V.A., Bocharov E.V., Pronyaeva T.R., Fedyuk N.V., Kukhanova M.K., Pokrovsky A.G. Uncharged AZT and D4T derivatives of phosphonoformic and phosphonoacetic acids as anti-HIV pronucleosides. J. Med. Chem., 2004, 47, №14, 3606-14.
57. Shirokova E.A., Jasko M.V., Khandazhinskaya A.L., Ivanov A.V., Yanvarev D.V., Scoblov Yu.S., Pronyaeva T.R., Fedyuk N.V., Pokrovsky A.G., Kukhanova M.K. New phosphonoformic acid derivatives of 3'-azido-3'-deoxythymidine. Russ. J. Bioorg. Chem., 2004, 30, №3, 273-280.
58. Jasko M.V., Ulanova N.Yu., Andronova V.L., Ivanov A.V., Karpenko I.L., Kukhanova M.K., Galegov G.A., Scoblov Yu.S. Synthesis and antiherpetic activity of acyclovir phosphonate esters Russ. J. Bioorg. Chem., 2004, 2004, 30, №6, 539-546.
59. Karpenko I.L., Jasko M.V., Andronova V.L., Ivanov A.V., Kukhanova M.K., Galegov G.A., Skoblov Yu.S. Synthesis and antiherpetic activity of acyclovir phosphonates, Nucleosides, Nucleotides & Nucleic Acids, 2003, 22 (3), 319-329.
60. Zakirova N.F., Ivanov A.V., Scoblov Yu.S., Kukhanova M.K. The influence of pyrophosphate analogs on E. coli inorganic pyrophosphatase activity. Russ. J. Bioorg. Chem., 2002, 28, №6, 497-501.
61. Ivanov A.V., Jasko M.V., Alexandrova L.A. Synthesis of -H-phosphono-- phosphonomethyl analogs of nucleoside-5’diphospates Russ. J. Bioorg. Chem., 2001, 27, №4, 300-302.
Reviews and chapters
62. Khomich O.A., Kochetkov S.N., Bartosch B., Ivanov A.V. Redox Biology of Respiratory Viral Infections. Viruses, 2018, 10, №8. 392.
63. Smirnova O.A., Bartosch B., Zakirova N.F., Kochetkov S.N., Ivanov A.V. Polyamine metabolism and oxidative protein folding in the ER as ROS-producing systems neglected in virology. Int. J. Mol. Sci., 2018, 19, № 4, E1219.
64. Ivanov A.V., Valuev-Elliston V.T., Tyurina D.A., Ivanova O.N., Kochetkov S.N., Bartosch B., Isaguliants M.G. Oxidative stress, a trigger of hepatitis B and C virus-induced carcinogenesis. Oncotarget. 2017, 8, №3, 3895-3932.
65. Ivanov A.V., Valuev-Elliston V.T., Ivanova O.N., Kochetkov S.N., Starodubova E.S., Bartosch B., Isaguliants M.G. Oxidative stress during HIV infection: mechanisms and consequences. Oxid. Med. Cell. Longev., 2016, vol. 2016, Article ID 8910396.
66. Ivanov A.V., Bartosch B., Smirnova O., Isaguliants M.G., Kochetkov S.N. HCV and oxidative stress in the liver. Viruses, 2013, 5, №2, 439-469.
67. Smirnova O.A., Ivanov A.V., Ivanova O.N., Valuev-Elliston V.T., Kochetkov S.N. Cellular systems of defense against oxidative stress and stress of endoplasmic reticulum: mechanisms of regulation and influence of hepatitis C virus. Molecular Biology (Moscow). 2011; 45(1), 127-141.
68. Alexander V Ivanov and Maxim V Jasko. Unsaturated acyclic nucleosides and nucleotides: synthesis and antiviral properties, Chapter in Frontiers in Nucleic Acids, ed. R.F. Schinazi and D.C. Liotta, IHL press, Tucker, GA, 2004, 365-399.
69. Ivanov A.V., Kuzyakin A.O., Kochetkov S.N. Molecular biology of hepatitis C virus, Uspehi biologicheskoy khimii [Advances in Biological Chemistry](Moscow). 2005, 45, 37-86.
Other papers
70. Ivanov A.V., Bartosch B., Isaguliants M.G. Editorial: Oxidative Stress in Infection and Consequent Disease. Oxid. Med. Cell. Longev., 2017, vol. 2017, published online. Article ID 3496043.
We use cookies on this site to enhance your user experience. By using our website, you are agreeing to allow the storage of cookies on your computer.